OPEN-ANGLE GLAUCOMA

This study tested a small medical device called the Hydrus Microstent in people with open-angle glaucoma that was difficult to control with standard treatments. The device is implanted during eye surgery to help lower internal eye pressure, which can prevent further vision damage…

This study tested two different laser eye treatment approaches for controlling eye pressure in people with glaucoma. Researchers compared treating the nasal side versus the bottom side of the eye with the same laser procedure. The goal was to find which approach works better to r…

This study tested two new eye drop formulas to see if they safely lower high eye pressure, a major risk factor for glaucoma. Over 400 adults with open-angle glaucoma or ocular hypertension used the drops for 7 or 28 days. Researchers compared the new drops to existing treatments …

This large, completed study compared a new investigational eye drop called NCX 470 to a standard medication (latanoprost) for treating open-angle glaucoma and ocular hypertension. The main goal was to see if the new drop was safe and effective at lowering high pressure inside the…

This study tested a different surgical approach for implanting a gel stent to treat open-angle glaucoma. Researchers implanted the device from outside the eye instead of inside to see if this method is safe and effective at reducing eye pressure. The study followed 74 patients fo…

This early-stage study tested a small, dissolving implant placed inside the eye to slowly release glaucoma medication over time. It involved 37 adults with mild-to-moderate glaucoma to find the safest and most effective dose. The goal was to see if this one-time implant could con…

This study tested how a new eye drop called NCX 470 affects fluid pressure inside the eye in people with or at risk for open-angle glaucoma. Researchers compared the eye drop to a placebo (inactive) solution in 18 participants over about 8 days. The goal was to understand if and …